Urovant Sciences® Announces Partnership with Thinx Inc. to Help

$ 23.00

4.6 (256) In stock

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced the launch of Time To GoTM today, a multi-channel educational camp

Cisco Launches Industry-First Partnering for Purpose Initiative - Cisco Blogs

POSEIDON CONCEPTS CORPORATION: BOOM TO BUST On

Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season

Endpoints News — Genentech touts Tecentriq combo data in liver cancer; Rep. Frank Pallone criticizes noncompliance with trial records law

Lenvatinib + Pembrolizumab as Frontline Therapy for Advanced Renal Cell Carcinoma

Urovant launches overactive bladder awareness campaign

AI generates proteins with exceptional binding strengths - UW Medicine

Voices of Power Up, America - Environmental Defense Fund

2022 AIM Tech Awards to honor community leaders in technology - Silicon Prairie News

US Coalition on Sustainability